Showing results (171-180 of 203) with videos related to
Sort By:
Pageof 21
Breast Cancer Research and Treatment|August 2, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective studyToshiaki Iwase, Nithya Sridhar, Megumi Kai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive ProteinShenying Fang, Dawen Sui, Yuling Wang, et al.Annals of Surgical Oncology|July 14, 2016
Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic ReconstructionStacey A Carter, Genevieve R Lyons, Henry M Kuerer, et al.JAMA Surgery|April 20, 2017
Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary SurgeryAudree B Tadros, Wei T Yang, Savitri Krishnamurthy, et al.Annals of Surgery|July 26, 2017
Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast ConservationAudree B Tadros, Benjamin D Smith, Yu Shen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapyRichard W Joseph, Vijay R Peddareddigari, Ping Liu, et al.Cancer|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.BMC Cancer|August 15, 2024
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNAJennifer H Chen, Sridevi Addanki, Dhruvajyoti Roy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Circulating Tumor Cells and Early Relapse in Node-positive MelanomaAnthony Lucci, Carolyn S Hall, Sapna P Patel, et al.Oncoimmunology|August 15, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanomaMerve Hasanov, Simin Kiany, Marie-Andrée Forget, et al.Pageof 21